InvestorsHub Logo
Followers 0
Posts 194
Boards Moderated 0
Alias Born 04/14/2024

Re: None

Wednesday, 04/17/2024 6:52:51 PM

Wednesday, April 17, 2024 6:52:51 PM

Post# of 42879
As previous owners of the patent LENZI, if the drug doesn't work and not effective why would Taran waste time lending 2 million to bid for a 'worthless' drug called lenzi that received more than 2.5 million in ip licensing fees from research firms for testing.
if the drug has no commercial use, the the molecule 'worthless so why bid for a worthless asset?